Skip to content
MedsAcross

Medicine

Methamphetamine 5 mg tablet

Available on requestPrescription onlyUS FDAControlled, schedule CIIGeneric name

Methamphetamine 5 mg tablet is a generic prescription medicine for oral use, made by 3 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20º to 25ºC (68º to 77ºF). Protect from light.

Key facts

Active ingredient (INN)
Methamphetamine
Brand
Sold under the generic name
Strength
5 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets
Manufacturers
Dr. Reddy's LaboratoriesIndiaHikma PharmaceuticalsMayne Pharma Commercial
Origin register
US FDA, United States
Storage
Store at 20º to 25ºC (68º to 77ºF). Protect from light.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Schedule CII
ATC code
N06BA03 Methamphetamine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
26 April 2010
Identifiers
RxCUI 977860DailyMed set ID d0905e2c-a02f-ec4f-59a3-6f7ad0acbbf6, 90c02ac6-e5e2-4c97-8c68-81e4e389a195, f31f580f-1f08-4a0f-b078-0b9e3308f712NDC 75907-094, 0054-0389, 68308-115Application ANDA091189, ANDA203846

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle, plastic75907-094-01Dr. Reddy's LaboratoriesIndia7 November 2025
100 tablet in 1 bottle0054-0389-25Hikma Pharmaceuticals6 December 2016
100 tablet in 1 bottle, plastic68308-115-01Mayne Pharma Commercial26 April 2010

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 31 December 1943Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Clinical summary

Methamphetamine is an amphetamine anorectic indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in pediatric patients 6 years of age and older. It is available as tablets for oral use. MedsAcross supplies Methamphetamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Methamphetamine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Methamphetamine 5 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.